NORDEA INVESTMENT MANAGEMENT AB
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 1218210
STOCKHOLM, V7
Position in ACAD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,078,061
-$1,269,436 QoQ
Shares Held
228,125
-4.0% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORDEA INVESTMENT MANAGEMENT AB holds $224,709,274 across 23 Biotechnology names. ACAD ranks #11 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
94,322 | $72,876,949 | |
| 2 | RPRX |
Royalty Pharma plc
|
788,022 | $37,801,414 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
306,439 | $19,213,724 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27,171 | $12,132,937 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
50,936 | $10,169,371 | |
| 6 | EXEL |
Exelixis, Inc.
|
201,553 | $8,644,607 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
113,902 | $6,434,323 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
51,821 | $5,461,932 |
All Filings in ACAD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,078,061 | 228,125 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $6,347,497 | 237,645 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $5,981,772 | 280,308 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $5,989,988 | 277,700 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $4,568,862 | 275,067 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,844,967 | 264,031 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $4,006,720 | 260,515 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $4,476,631 | 275,485 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $5,963,098 | 322,504 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $18,347,722 | 586,002 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $12,470,718 | 598,403 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $14,335,943 | 598,578 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $10,940,329 | 581,314 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $9,782,633 | 614,487 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $10,234,227 | 625,564 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $8,877,827 | 630,080 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $15,004,895 | 619,525 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $14,255,115 | 610,759 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $10,225,630 | 615,631 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $11,214,814 | 459,812 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $389,322 | 15,090 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||